We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FDA Releases Draft Guidance Documents on New Expedited Access Program for Premarket Approval of Medical Devices and Premarket and Postmarket Data Collection

08 May 2014
On 23 April 2014, the Food and Drug Administration (FDA) released two related draft guidance documents related to premarket approval (PMA) applications for medical devices. The first outlines an expedited access PMA program, building off the pilot Innovation Pathway program. The second addresses the agency's plans for balancing premarket and postmarket data collection efforts. Both guidances are put forth by the agency as an effort to streamline FDA approval for devices addressing important medical needs.

Gerry Prud'homme

Janice Hogan

Uta Rawson

Yarmela Pavlovic

Loading data